← FDA Drug Approvals (Drugs@FDA)
HYRIMOZ
BLA · Biologics License Application · Sponsor: SANDOZ INC · Approved 2018-10-30
Drug application
- FDA Application #
BLA761071- Application type
- Biologics License Application
- Brand name
- HYRIMOZ
- Generic name
- ADALIMUMAB-ADAZ
- Active ingredients
- ADALIMUMAB-ADAZ
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SANDOZ INC
- Manufacturer
- Sandoz Inc
- First approval
- 2018-10-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown